Hong Kong cuts hotel quarantine for travelers to 3 days, plus 4 days of home medical surveillance

Hong Kong cuts hotel quarantine for travelers to 3 days, plus 4 days of home medical surveillance


Hong Kong is reducing the amount of time travelers will need to serve hotel quarantine, from seven days down to three starting Friday.

“The seven-day quarantine hotel arrangement will be changed to three days in a quarantine hotel, plus four days of home medical surveillance,” Chief Executive John Lee said at a press conference Monday.

After completing the hotel quarantine, travelers can stay at home or in a hotel for the four days of surveillance. During this period people will be able to leave their place of residence, but cannot enter “places where there is active checking of vaccine passes,” Lee said in Cantonese.

That includes bars, pubs, gyms and beauty parlors. People are also not allowed to visit nursing homes, schools and specified medical premises during the surveillance period.

“They cannot participate in any activities where masks are to be taken off,” Lee added. If they test negative on a rapid antigen test, they can take public transportation, go to work and enter shopping malls, he said.

“We have to strike a balance between risk level as well as our economic activity. Where risks could be controlled, we want to preserve maximum movement of people and to maintain Hong Kong’s competitiveness,” Lee said.

CNBC Health & Science

Read CNBC’s latest global health coverage:



Source

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to  billion
Health

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to $12 billion

A startup widely known as “ChatGPT for doctors” raised a new funding round that values the company at $12 billion. OpenEvidence, based in Miami, Florida, closed a $250 million financing, led by Thrive Capital and DST, the company told CNBC. The startup first raised outside capital in February, when it reeled in $75 million from […]

Read More
Another alliance of health care and AI signals why pharma stocks should be back in favor
Health

Another alliance of health care and AI signals why pharma stocks should be back in favor

Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the latest way health care and artificial intelligence are rapidly intersecting. Bristol Myers said on Tuesday it will work with Microsoft’s AI-powered radiology platform to develop and launch imaging algorithms. These new tools, which can be used to […]

Read More
Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry
Health

Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry

US President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, DC, US, on Friday, Dec. 19, 2025. Will Oliver | Bloomberg | Getty Images Drug pricing. Looming patent cliffs. Dealmaking. The first year of Trump 2.0. Those are among the themes that dominated conversations last week as drugmakers […]

Read More